Success Rate of Partial Two-Stage Exchange Arthroplasty for Late Chronic Periprosthetic Joint Infections in Total Hip Arthroplasty: A Meta-Analysis
Hip & Pelvis · 01.06.2026 · 38 (2) · 145-154
DOI: 10.5371/hp.2026.38.2.145 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Hip & Pelvis, erschienen am 01.06.2026. Verfasst von Byung-Ho Yoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Hip Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
- Ewha Womans University College of Medicine, Seoul, Korea.
ORCID-Profile: Byung-Ho Yoon, Suyeon Park, Eunseo Joung, Naye Kang, Nah Yon Kim, Ki Tae Park
Förderung
- Korean Hip Society
Zitieren
APA
Yoon, B. H., Park, S., Joung, E., Kang, N., Kim, N. Y., & Park, K. T. (2026). Success Rate of Partial Two-Stage Exchange Arthroplasty for Late Chronic Periprosthetic Joint Infections in Total Hip Arthroplasty: A Meta-Analysis. Hip & Pelvis, 38(2), 145-154. https://doi.org/10.5371/hp.2026.38.2.145
Vancouver
Yoon BH, Park S, Joung E, Kang N, Kim NY, Park KT. Success Rate of Partial Two-Stage Exchange Arthroplasty for Late Chronic Periprosthetic Joint Infections in Total Hip Arthroplasty: A Meta-Analysis. Hip & Pelvis. 2026;38(2):145-154. doi:10.5371/hp.2026.38.2.145
BibTeX
@article{Yoon2026,
author = {Yoon, Byung-Ho and Park, Suyeon and Joung, Eunseo and Kang, Naye and Kim, Nah Yon and Park, Ki Tae},
title = {Success Rate of Partial Two-Stage Exchange Arthroplasty for Late Chronic Periprosthetic Joint Infections in Total Hip Arthroplasty: A Meta-Analysis},
journal = {Hip & Pelvis},
year = {2026},
volume = {38},
number = {2},
pages = {145--154},
doi = {10.5371/hp.2026.38.2.145}
}
EUVIMED